• Nutrition Research and Practice
• /
• v.13 no.1
• /
• pp.23-31
• /
• 2019

BACKGROUND/OBJECTIVES: A large number of studies on anemia have focused mostly on pregnant women or children. The vegetarian population, which is another potential risk group for anemia, remains largely unexplored. Therefore, this cross-sectional study examined the associations of the sociodemographic, lifestyle, nutritional, and psychological factors with the anemia status among female adult vegetarians. SUBJECTS/METHODS: A total of 177 female vegetarians were recruited from a Buddhist and Hindu organization in Selangor, Malaysia. The participants completed a self-administered questionnaire, which analyzed their sociodemographic characteristics, physical activity level, sleep quality, depression, anxiety, and stress. The body weight, height, waist circumference, and body fat percentage of the participants were also measured. A 3-day dietary recall was conducted to assess their dietary intake. Blood samples (3 ml) were withdrawn by a nurse from each participant to determine the hemoglobin (Hb) level. RESULTS: The findings revealed 28.2% of the participants to be anemic. The age group (AOR = 2.46, 95% CI = 1.19-5.05), marital status (AOR = 2.69, 95% CI = 1.27-5.71), and percentage of energy from protein (AOR = 5.52, 95% CI = 1.41-21.65) were the significant predictors of anemia. CONCLUSIONS: Anemia is a public health problem among female vegetarians in this study. Health promotion programs that target female adult vegetarians should be conducted to manage and prevent anemia, particularly among those who are married, aged 50 and below, and with an inadequate protein intake.

• Journal of Yeungnam Medical Science
• /
• v.39 no.3
• /
• pp.244-249
• /
• 2022

Background: Chronic infectious, inflammatory, or neoplastic disorders are associated with anemia of chronic disease. Chronic inflammatory diseases such as periodontitis may contribute to masked anemia, especially in smokers. This study was aimed at verifying and comparing the efficacy of nonsurgical periodontal therapy (NSPT) for improving anemia among chronic periodontitis patients with and without the habit of smoking. Methods: Thirty systemically healthy individuals with chronic periodontitis were divided into two groups of 15 each, smokers (group A) and nonsmokers (group B). The groups were compared based on hematological parameters such as serum erythropoietin (SE) and serum ferritin (SF) levels at baseline and 3 months after NSPT for anemia evaluation. Results: The baseline SE levels in groups A and B were 11.84 and 15.19 mIU/mL (p=0.031), respectively; the corresponding levels at 3 months after NSPT were 13.00 and 17.74 mIU/mL (p=0.022). The baseline SF levels in groups A and B were 95.49 and 44.86 ng/mL (p=0.018), respectively; the corresponding levels at 3 months after NSPT were 77.06 and 39.05 ng/mL (p=0.009). Group B showed a significant increase and decrease in the SE and SF levels, respectively, at 3 months after NSPT (p=0.035 and p=0.039, respectively), whereas group A showed insignificant changes (p=0.253 and p=0.618, respectively). Conclusion: NSPT led to an improvement in anemia among chronic periodontitis patients. However, the improvement is less in smokers compared to that in nonsmokers. Furthermore, SF and SE levels might serve as effective biomarkers for assessing anemia in smokers and nonsmokers with chronic periodontitis.

• Journal of Pharmaceutical Investigation
• /
• v.6 no.3
• /
• pp.20-25
• /
• 1976

Deer horn lowered the rate of anemia induction by phenylhydrazine and rapidly recovered from the anemia state.

• Journal of Sasang Constitutional Medicine
• /
• v.15 no.2
• /
• pp.89-93
• /
• 2003

Pernicious anemia is a pathologic state due to lack of Vit.B12 or folic acid. Pernicious anemia is due to metabolic disorder including poor absorption of stomach through gastroectomy. We experienced a 76 year old male patient diagnosed as pernicious anemia for perfomed total gastroectomy. Herbal medicine that we had was mainly treated and several remarkable changes have been showed. This is a clinical report of that patient.

• Childhood Kidney Diseases
• /
• v.19 no.1
• /
• pp.43-47
• /
• 2015

Hemolytic anemia and thrombocytopenia are rare clinical manifestations of acute glomerulonephritis. Initially, in all such cases, a diagnosis of hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, systemic lupus erythematosus, and amyloidosis should be ruled out. The presence of hemolytic anemia and thrombocytopenia is rare, but possible, in a case of acute poststreptococcal glomerulonephritis, and may result in delayed diagnosis or misdiagnosis. Correct and timely diagnosis would ensure adequate treatment in such patients. We report of a 22-month-old boy with acute glomerulonephritis coexistent with hemolytic anemia and idiopathic thrombocytopenia.

• Korean Journal of Veterinary Research
• /
• v.57 no.2
• /
• pp.139-141
• /
• 2017

An 8-year-old castrated male Shih Tzu dog (weighing 7.0 kg) presented with anemia and lethargy. Initial diagnosis indicated immune-mediated hemolytic anemia. During therapy, a secondary urinary infection, probably due to the immune suppressive therapy, was diagnosed. Subsequent diagnostic tests, including urinalysis and urine culture, indicated candidal cystitis. Despite ketoconazole therapy for candidal cystitis, the dog died suddenly. A Candida albicans infection was confirmed upon postmortem evaluation. Prolonged immunosuppressive therapy might be the cause of this infection. This is the first case report describing a Candida albicans urinary tract infection accompanied by hemolytic anemia in a dog in Korea.

• The Journal of Internal Korean Medicine
• /
• v.25 no.4
• /
• pp.356-363
• /
• 2004

Iron Deficiency Anemia is defined as deficiency Fe in blood. The causal relationships between this and gastrointestinal bleeding, impaired absorption, excessive menstrual flow and other maladies are not well understood. In oriental medicine Iron Deficiency Anemia is generally characterized as deficiency of ki(氣)and blood(血) defined in terms of hypofunction of the spleen and stomach, and insufficiency of the spleen and kindneys. Two Iron Deficiency Anemia patients were treated with Ickibohyoul-tang, Samchulgunbi-tang, Ickibohyoul-tang ga antler, and Sachulgunbi-tang ga antler. Symptoms improved and Blood exams (RBC, Hb, Hct) yielded higher counts. Further research concerning this is necessary.

• The Journal of Internal Korean Medicine
• /
• v.41 no.3
• /
• pp.508-514
• /
• 2020

Objectives: This case reports on the effect of Shipjeondaebo-tang-gami in a patient with anemia. Methods: We used Shipjeondaebo-tang-gami to treat a patient suffering from anemia. We evaluated the improvement of symptoms using biochemical examination of a blood sample and the visual analogue scale (VAS). Results: The patients showed improvement in the clinical symptoms and laboratory results for the biochemical blood tests. Conclusions: This study shows that Korean medical treatment with Shipjeondaebo-tang-gami may be valuable for anemia.

• Korean Journal of Veterinary Research
• /
• v.61 no.4
• /
• pp.33.1-33.5
• /
• 2021

This study reports the detection and genotyping of the first clinical case of bovine anemia due to Theileria orientalis group (BATOG) in non-grazed dairy cow in upper South Korea. Blood and serum tests revealed anemia and hyperbilirubinemia from animal showing clinical symptoms, and later confirmed as piroplasmosis-positive. Follow-up surveillance on the herd revealed 2 asymptomatic cows with anemia. The three animals were confirmed theileriosis-positive and genotyping revealed the clinical and one of the asymptomatic cases have Chitose, while the other has Ikeda genotype. Clinical BATOG cases were rarely reported worldwide, and asymptomatic animals left untreated could serve as parasite reservoir.

• Journal of The Korean Society of Clinical Toxicology
• /
• v.4 no.2
• /
• pp.170-174
• /
• 2006

Methylene blue is a basic thiazine dye frequently used for histologic staining. In clinical toxicology settings, it is also used to treat clinically significant methemoglobinemia. It has dose-dependent oxidation or reduction properties, acting as a reducing agent at lower doses and as an oxidizing agent at higher doses. Hemolytic anemia and hyperbilirubinemia are known toxic effects of methylene blue treatment that have been reported clinically. A 42-year-old woman developed significant methemoglobinemia after acute dapsone overdose; she was treated appropriately with intravenous methylene blue in the therapeutic range. The patient's methemoglobin levels returned to normal. However, 2-4 days later she was noted to have rebound methemoglobinemia, hemolytic anemia, and hyperbilirubinemia. A repeat of Coomb's test and other anemia workups were negative. For management of methylene blue-induced hemolytic anemia, she was administered steroid therapy, N-acetylcysteine, and a blood transfusion. She ultimately recovered, and there were no long-term sequelae from the methylene blue poisoning.